No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
No Data
A Quick Look at Today's Ratings for Ionis Pharmaceuticals(IONS.US), With a Forecast Between $48 to $82
Express News | Ionis Pharmaceuticals Inc : TD Cowen Raises Target Price to $59 From $54
TD Cowen Keeps Their Buy Rating on Ionis Pharmaceuticals (IONS)
Express News | Ionis Pharmaceuticals Inc : BofA Global Research Raises Price Objective to $68 From $67
Buy Rating on Ionis Pharmaceuticals Backed by Strong Trial Results for Angelman Syndrome Drug
Analysts Offer Insights on Healthcare Companies: Ionis Pharmaceuticals (IONS), Lifestance Health Group (LFST) and Agilent (A)
No Data